StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
PAHC

Phibro Animal Health Corporation

PAHC Nasdaq Pharmaceutical Preparations EDGAR ↗
$37.15
+0.70 +1.92%

Key statistics

from XBRL data in SEC filings
Market cap
$1.52B
Revenue (TTM)
$1.50B
Net income (TTM)
$95.2M
EPS (TTM)
$2.34
P/E ratio
15.9
Dividend yield
1.29%
Free cash flow
$41.8M
Cash
$54.9M
Total assets
$1.45B
Gross margin
32.5%
52-week range
$26.08 – $60.08

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 28, 2026 8-K Director or officer change Jun 26, 2026 8-K Results of operations (earnings release) May 6, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Other events May 5, 2026 8-K Entered a material agreement; Took on a direct financial obligation Apr 30, 2026 8-K Regulation FD disclosure Apr 27, 2026 8-K Director or officer change Apr 14, 2026 8-K Results of operations (earnings release) Feb 4, 2026 10-Q Quarter ended 2025-12-31 Feb 4, 2026 8-K Other events Feb 3, 2026 8-K Director or officer change; Regulation FD disclosure Dec 18, 2025 8-K Results of operations (earnings release); Shareholder vote results Nov 5, 2025 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Other events Nov 4, 2025 8-K Results of operations (earnings release) Aug 27, 2025 10-K Fiscal year ended 2025-06-30 Aug 27, 2025 8-K Other events Jul 29, 2025 8-K Results of operations (earnings release) May 7, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Other events May 6, 2025 8-K Results of operations (earnings release) Feb 5, 2025 10-Q Quarter ended 2024-12-31 Feb 5, 2025 8-K Other events Feb 4, 2025 8-K Director or officer change Jan 23, 2025 8-K/A Jan 7, 2025 8-K Director or officer change Nov 12, 2024 8-K Results of operations (earnings release); Shareholder vote results Nov 6, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Other events Nov 5, 2024 8-K Completed an acquisition or disposition; Took on a direct financial obligation; Regulation FD disclosure Oct 31, 2024 8-K Results of operations (earnings release) Aug 28, 2024 10-K Fiscal year ended 2024-06-30 Aug 28, 2024 8-K Other events Jul 30, 2024 8-K Entered a material agreement; Took on a direct financial obligation Jul 9, 2024 8-K Results of operations (earnings release) May 8, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Other events May 7, 2024 8-K Entered a material agreement; Regulation FD disclosure Apr 29, 2024 8-K Results of operations (earnings release) Feb 7, 2024